comparemela.com
Home
Live Updates
Prnewsfoto Immvira - Breaking News
Pages:
Latest Breaking News On - Prnewsfoto immvira - Page 1 : comparemela.com
ImmVira announced to launch the construction of Global R&D and Commercialization Base
SHENZHEN, China, Oct. 18, 2022 /PRNewswire/ On October 18, 2022, ImmVira launched the construction of its Global R&D and Commercialization Base.
United states
Prnewsfoto immvira
Guoying zhou
Clinical center
Commercialization base
Suzhou wuzhong biomedical industrial park
Shanghai north bund
Shanghai business
ImmVira enters clinical development in combination therapy of MVR-T3011 IT and MEK inhibitor in the U S
SHENZHEN, China, April 19, 2022 /PRNewswire/ ImmVira announced that, company has reached a cooperation agreement with Roche to establish clinic.
United states
Prnewsfoto immvira
Prnewswire immvira
Therapeutic efficacy
Oncolytic herpes simplex virus
Mutated colorectal
Lung carcinoma
Grace zhou
ImmVira s MVR-T3011 IV completed first 2 cohorts dose-escalation of U S Phase I clinical study with favorable safety data
SHENZHEN, China, Jan. 18, 2022 /PRNewswire/ ImmVira s breakthrough product MVR-T3011 IV, global first clinical-stage oncolytic herpes simplex v.
Prnewsfoto immvira
Prnewswire immvira
Guoying zhou
vimarsana © 2020. All Rights Reserved.